The In Vitro Lung Model Market size was valued at USD 274.13 million in 2022 and is expected to reach USD $ 883.65 million by 2029, at a CAGR of 18.2% during the forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report
In Vitro Lung Model Market Overview:
In vitro models of the human lung are also likely to provide powerful platforms for large-scale screens, molecular-level analysis of cell-cell interactions, and the potential to study or treat lung disorders with personalized medicine. The report covers the current estimate and forecast for in Vitro Lung Model Market on a global and regional level. The report provides an in-depth analysis of the In Vitro Lung Model Market for the period 2023 – 2029, wherein 2022 is the base year and the period from 2023 to 2029 is the forecast period. Data for 2017- 2022 has been included as historical information. The study provides a detailed perspective on market growth, throughout the forecast period in terms of revenue estimates (in US$ MN), across different geographies, which include North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM). The report provides qualitative and quantitative insights on the In Vitro Lung Model industry trends and a detailed analysis of the market size and growth rate of all segments in the market. The market is segmented by Type, Application, and Region. Key players covered in the report of global in vitro lung model market are Epithelix, MatTek Corporation, Lonza, ATCC, InSphero, Emulate, AlveoliX AG, Oncotheis, Insphero, TissUse, Mimetas, CN Bio Innovations, Thermo Fisher Scientific Inc., PromoCell GmbH, Merck KGaA, Hoziron Discovery Group plc.In Vitro Lung Model Market Dynamics:
Many differences between animal and human lung physiology, create an unmet need for human lung model systems that can complement animal models to improve our understanding of human lung physiology. Upsurge population suffering from lung fibrosis & emphysema, lung cancer, and other respiratory disorders led the research into in vitro lung model. The ability of in vitro lung model to relate and accurately recapitulate complexities of human biology is to create the opportunities for the growth of global market by improving the understanding for cell mechanism. Hence, this in vitro lung model increases the ability to treat patients having lung diseases. Growing interest of scientists in cell biology and biochemistry study acts as a driver for growth of the global in-vitro lung model market. 2D Cell Model segment commanded the largest market share for their positive results in treatment of bronchiectasis and pulmonary function disorders. The powerful research in the cell-cell interaction in in-vitro lung models creates opportunities for the global in vitro lung model market in the forecast period. 2D cell lung model examines cell-based responses, physiologic functions, drug toxicity, and drug responses, which led to the growth of the global market results in a growing number of treatments and surgeries for lung diseases. The drug screening & toxicology segment is expected to expand at a significant CAGR of 9.0% during the forecast period. An increase in research and development of new drugs and rising demand for in vitro lung models for lung transplantation are anticipated to grow the global market. Government facilities and expenditure for research and development across the pharmaceutical sector, biochemistry labs, national cell science centers are also boosting the global long model market. Human model systems that reliably and accurately recapitulate the complexities of human biology in vitro should help to improve our understanding of and ability to treat human lung disease. Europe commanded the largest market share of 18.2% by 2029. Europe commanded the largest market share of xx % during the forecast period for their availability of lots of literature studies for in vitro lung models. An increase in research funding from various organizations and a rise in research and development activities by various pharmaceutical and biotechnology companies propel the growth of the global in-vitro lung model market in Europe. Rising cases of asthma, lung cancer, and COPD are the major factors driving in vitro lung model market.Vitro Lung Model Market Scope:Inquire before buying
Vitro Lung Model Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 274.13 Mn. Forecast Period 2023 to 2029 CAGR: 18.2% Market Size in 2029: US $ 883.65 Mn. Segments Covered: by Type • 2D Cell Model • 3D Cell Model by Application • Drug Screening & Toxicology • Basic Research • 3D Model Development • Physiologic Research • Stem Cell Research • Regenerative Medicine In Vitro Lung Model Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Vitro Lung Model Market Key Players
• Epithelix • MatTek Corporation • Lonza • ATCC • InSphero • Emulate • AlveoliX AG • Oncotheis • Insphero • TissUse • Mimetas • CN Bio Innovations • Thermo Fisher Scientific Inc. • PromoCell GmbH • Merck KGaA • Hoziron Discovery Group plc Frequently Asked Questions: 1. Which region has the largest share in Global Vitro Lung Model Market? Ans: Europe region held the highest share in 2022. 2. What is the growth rate of Global Vitro Lung Model Market? Ans: The Global Vitro Lung Model Market is growing at a CAGR of 18.2% during forecasting period 2023-2029. 3. What is scope of the Global Vitro Lung Model Market report? Ans: Global Vitro Lung Model Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Vitro Lung Model Market? Ans: The important key players in the Global Vitro Lung Model Market are – Epithelix, MatTek Corporation, Lonza, ATCC, InSphero, Emulate, AlveoliX AG, Oncotheis, Insphero, TissUse, Mimetas, CN Bio Innovations, Thermo Fisher Scientific Inc., PromoCell GmbH, Merck KGaA, Hoziron Discovery Group plc 5. What is the study period of this Market? Ans: The Global Vitro Lung Model Market is studied from 2022 to 2029.
1. In Vitro Lung Model Market: Research Methodology 2. In Vitro Lung Model Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to In Vitro Lung Model Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. In Vitro Lung Model Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. In Vitro Lung Model Market Segmentation 4.1 In Vitro Lung Model Market, by Type (2022-2029) • 2D Cell Model • 3D Cell Model 4.2 In Vitro Lung Model Market, by Application (2022-2029) • Drug Screening & Toxicology • Basic Research • 3D Model Development • Physiologic Research • Stem Cell Research • Regenerative Medicine 5. North America In Vitro Lung Model Market(2022-2029) 5.1 North American In Vitro Lung Model Market, by Type (2022-2029) • 2D Cell Model • 3D Cell Model 5.2 North America In Vitro Lung Model Market, by Application (2022-2029) • Drug Screening & Toxicology • Basic Research • 3D Model Development • Physiologic Research • Stem Cell Research • Regenerative Medicine 5.3 North America In Vitro Lung Model Market, by Country (2022-2029) • United States • Canada • Mexico 6. Asia Pacific In Vitro Lung Model Market (2022-2029) 6.1. Asia Pacific In Vitro Lung Model Market, by Type (2022-2029) 6.2. Asia Pacific In Vitro Lung Model Market, by Application (2022-2029) 6.2. Asia Pacific In Vitro Lung Model Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa In Vitro Lung Model Market (2022-2029) 7.1. Middle East and Africa In Vitro Lung Model Market, by Type (2022-2029) 7.2. Middle East and Africa In Vitro Lung Model Market, by Application (2022-2029) 7.3. Middle East and Africa In Vitro Lung Model Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America In Vitro Lung Model Market (2022-2029) 8.1. Latin America In Vitro Lung Model Market, by Type (2022-2029) 8.2. Latin America In Vitro Lung Model Market, by Application (2022-2029) 8.3 Latin America In Vitro Lung Model Market, by Country (2022-2029) • Brazil • Argentina • Rest Of Latin America 9. European In Vitro Lung Model Market (2022-2029) 9.1. European In Vitro Lung Model Market, by Type (2022-2029) 9.2. European In Vitro Lung Model Market, by Application (2022-2029) 9.3 European In Vitro Lung Model Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Epithelix. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. MatTek Corporation 10.3. Lonza 10.4. ATCC 10.5. InSphero 10.6. Emulate 10.7. AlveoliX AG 10.8. Oncotheis 10.9. Insphero 10.10. TissUse 10.11. Mimetas 10.12. CN Bio Innovations 10.13. Thermo Fisher Scientific Inc. 10.14. PromoCell GmbH 10.15. Merck KGaA 10.16. Hoziron Discovery Group plc